Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Revenue (2016 - 2025)

Avanos Medical (AVNS) has disclosed Revenue for 13 consecutive years, with $180.9 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 0.72% to $180.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $701.2 million through Dec 2025, up 1.95% year-over-year, with the annual reading at $701.2 million for FY2025, 1.95% up from the prior year.
  • Revenue hit $180.9 million in Q4 2025 for Avanos Medical, up from $177.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $197.4 million in Q1 2022 to a low of $35.8 million in Q4 2021.
  • Historically, Revenue has averaged $168.6 million across 5 years, with a median of $172.8 million in 2022.
  • Biggest five-year swings in Revenue: tumbled 80.65% in 2021 and later skyrocketed 407.26% in 2022.
  • Year by year, Revenue stood at $35.8 million in 2021, then surged by 407.26% to $181.6 million in 2022, then dropped by 4.57% to $173.3 million in 2023, then rose by 3.64% to $179.6 million in 2024, then grew by 0.72% to $180.9 million in 2025.
  • Business Quant data shows Revenue for AVNS at $180.9 million in Q4 2025, $177.8 million in Q3 2025, and $175.0 million in Q2 2025.